Clinical Trial Update: Serum and Synovium Protease Inhibitor Levels in Primary and Secondary Osteoarthritic Joints

View source ↗

Summary

A clinical trial evaluating serum and synovium protease inhibitor levels in primary and secondary osteoarthritis joints has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteoarthritis of the Knee

Snippet

Sponsor: Scuderi, Gaetano J., M.D. | Conditions: Osteoarthritis of the Knee | Status: SUSPENDED